Reuters logo
Actavis sues FDA over generic Celebrex
April 28, 2014 / 9:51 PM / 4 years ago

Actavis sues FDA over generic Celebrex

April 28 (Reuters) - Actavis Plc on Monday said it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc’s blockbuster painkiller Celebrex.

The move follows a similar lawsuit announced Friday by Mylan Inc over generic drug marketing exclusivity for Celebrex. (Reporting by Susan Kelly in Chicago; Editing by Bernard Orr)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below